Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment
Agustí A, Halpin DMG, Celli B, Vogelmeier CF. Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment. Eur Respir J. 2026 Jul 23;68(1):2600549. doi: 10.1183/13993003.00549-2026. PMID: 42492984
Moving to better COPD care-changes to and challenges for GOLD
Vogelmeier CF, Halpin DMG, Criner GJ, Martinez FJ, Singh D, Anzueto A, Agusti A; GOLD Science Committee. Moving to better COPD care-changes to and challenges for GOLD. Am J Respir Crit Care Med. 2026 Jul 8:aamag256. doi: 10.1093/ajrccm/aamag256. Epub ahead of print. PMID: 42417382..
Agusti A, Vila M, Faner R, Trinkmann F, Janssens W, Halpin DMG, Celli BR, Zheng J, Criner G, Aaron SD, Roche N, Fabbri L, Han M, Sin DD, Martínez FJ, Papi A, Troosters T, Anzueto A, Ozoh OB, Wedzicha J, Salvi S, Singh D, Montes de Oca M, Pavord I, Bourbeau J, Vogelmeier CF. How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD. Am J Respir Crit Care Med. 2026 Jun 30:aamag337. doi: 10.1093/ajrccm/aamag337. Epub ahead of print. PMID: 42377276.
A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPD
Dave Singh, Alvar Agustí, Jean Bourbeau, Fernando J Martinez, David M G Halpin, Claus F Vogelmeier, A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPD, American Journal of Respiratory and Critical Care Medicine, 2026;, aamag231, https://doi.org/10.1093/ajrccm/aamag231
GOLD International COPD Conference 2025 proceedings
Gerard Criner; GOLD International COPD Conference 2025 proceedings. Respiration 2026; https://doi.org/10.1159/000551327
Halpin DMG, Stanojevic S, McCormack MC, Singh D, Kamkinsky D, Vogelmeier CF, Gochicoa-Rangel L, Agusti A, Cooper B. Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD, European Respiratory Journal, https://doi.org/10.1183/13993003.02574-2025
David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, Obianuju B Ozoh, Alvaro A Cruz, Helen K Reddel, Arzu Yorgancıoğlu, Alvar Agusti, Addressing the global challenges of chronic obstructive pulmonary disease and asthma: a shared vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA), American Journal of Respiratory and Critical Care Medicine, https://doi.org/10.1164/rccm.202508-1894PP
Ozoh OB, Ogundare A, Ozoh CT, Tekobo A. Raising chronic obstructive pulmonary disease awareness in Africa: Time to walk the talk. J Pan Afr Thorac Soc. 2024;5:89-91. doi: 10.25259/JPATS_28_2024
GOLD 2024: a brief overview of key changes
Agusti1 A, Vogelmeier2 CF. GOLD 2024: a brief overview of key changes. J Bras Pneumol. 2023;49(6):e20230369
Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022
Halpin DMG, Vogelmeier CF, Agusti A. Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022. Am J Respir Crit Care Med. 2022 Sep 15;206(6):669-671. doi: 10.1164/rccm.202207-1407ED. PMID: 36112775; PMCID: PMC9799120.
Stolbrink M, Thomson H, Hadfield RM, Ozoh OB, Nantanda R, Jayasooriya S, Allwood B, Halpin DMG, Salvi S, de Oca MM, Mortimer K, Rylance S. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review. Lancet Glob Health. 2022 Oct;10(10):e1423-e1442. doi: 10.1016/S2214-109X(22)00330-8. PMID: 36113528; PMCID: PMC9638033.
Singh D, Agusti A, Martinez FJ, Papi A, Pavord ID, Wedzicha JA, Vogelmeier CF, Halpin DMG. Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. Am J Respir Crit Care Med. 2022 Jul 1;206(1):17-24. doi: 10.1164/rccm.202201-0209PP. PMID: 35737975.